We are live on
!
Find out more
CIC
Carnegie Investment Counsel Portfolio holdings
AUM
$4.99B
1-Year Est. Return
23.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.81%
1 Year Est. Return
+23.08%
3 Year Est. Return
+101.05%
5 Year Est. Return
+118.22%
10 Year Est. Return
+474.28%
AUM
$1.22B
AUM Growth
-$95.1M
(-7.2%)
Cap. Flow
-$71M
Cap. Flow
% of AUM
-5.83%
Top 10 Holdings %
Top 10 Hldgs %
20.97%
Holding
411
New
32
Increased
199
Reduced
101
Closed
70
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$16.3M |
| 2 |
Neogen
NEOG
|
+$11M |
| 3 |
Amazon
AMZN
|
+$8.31M |
| 4 |
DuPont de Nemours
DD
|
+$7.77M |
| 5 |
Sherwin-Williams
SHW
|
+$7.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$36.6M |
| 2 |
Wells Fargo
WFC
|
+$20M |
| 3 |
Visa
V
|
+$13.6M |
| 4 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$11.3M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.11% |
| 2 | Industrials | 12.38% |
| 3 | Healthcare | 11.16% |
| 4 | Technology | 10.52% |
| 5 | Consumer Discretionary | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
State Street SPDR S&P 500 ETF Trust
SPY
$808B
| $13M | 1.07% |
47,559
-25,546
| -35% | -$7.27M |
|
27
Nike
NKE
$60.8B
| $12.5M | 1.03% |
167,984
+28,440
| +20% | +$2.28M |
|
28
Cisco
CSCO
$474B
| $12M | 0.99% |
259,084
+53,497
| +26% | +$2.41M |
|
|
ANSS
29
DELISTED
Ansys
ANSS
| $12M | 0.98% |
75,434
+17,660
| +31% | +$3.16M |
|
30
Meta Platforms (Facebook)
META
$1.54T
| $12M | 0.98% |
85,887
+30,669
| +56% | +$5.55M |
|
31
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $11.1M | 0.91% |
138,559
+39,031
| +39% | +$3.78M |
|
32
Lowe's Companies
LOW
$125B
| $10.4M | 0.86% |
111,964
-12,139
| -10% | -$1.26M |
|
|
DNKN
33
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $10.1M | 0.83% |
137,405
+25,476
| +23% | +$1.84M |
|
34
AbbVie
ABBV
$439B
| $9.2M | 0.75% |
100,581
+2,497
| +3% | +$237K |
|
35
Procter & Gamble
PG
$337B
| $9.1M | 0.75% |
97,105
-3,933
| -4% | -$322K |
|
|
SLY
36
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $8.5M | 0.7% |
124,197
+57,635
| +87% | +$4.37M |
|
37
Huntington Bancshares
HBAN
$35.9B
| $7.91M | 0.65% |
534,340
+135,842
| +34% | +$2.12M |
|
38
Mettler-Toledo International
MTD
$28.8B
| $7.9M | 0.65% |
13,170
+2,736
| +26% | +$1.61M |
|
39
Bristol-Myers Squibb
BMY
$130B
| $7.88M | 0.65% |
145,575
+22,461
| +18% | +$1.33M |
|
40
Eaton
ETN
$178B
| $7.83M | 0.64% |
105,645
+23,802
| +29% | +$1.95M |
|
41
State Street Financial Select Sector SPDR ETF
XLF
$59.2B
| $7.78M | 0.64% |
291,035
+111,458
| +62% | +$3.12M |
|
|
PRAH
42
DELISTED
PRA Health Sciences, Inc.
PRAH
| $7.75M | 0.64% |
77,018
+17,052
| +28% | +$1.78M |
|
43
Amgen
AMGN
$224B
| $7.69M | 0.63% |
39,431
-15,463
| -28% | -$3.05M |
|
44
Vanguard Morningstar Total Stock Market ETF
VTI
$690B
| $7.61M | 0.62% |
54,384
+8,573
| +19% | +$1.26M |
|
45
Stryker
SYK
$134B
| $7.46M | 0.61% |
43,315
+530
| +1% | +$90.5K |
|
46
PepsiCo
PEP
$188B
| $7.27M | 0.6% |
61,307
+7,478
| +14% | +$847K |
|
47
Waste Management
WM
$91.4B
| $7.03M | 0.58% |
75,817
+14,416
| +23% | +$1.28M |
|
48
Pfizer
PFE
$151B
| $6.97M | 0.57% |
168,788
+40,193
| +31% | +$1.55M |
|
49
Vanguard Morningstar Mid-Cap ETF
VO
$110B
| $6.95M | 0.57% |
182,164
+77,696
| +74% | +$3.17M |
|
50
Abbott
ABT
$190B
| $6.94M | 0.57% |
96,310
+30,693
| +47% | +$2.02M |
|
Similar funds
MA
SNT
AM
SGM
PAMP
BCM
NL
O
Carnegie Investment Counsel's Q3 2018 Portfolio in Review
As of Q3 2018, Carnegie Investment Counsel held 411 positions worth $1.22B, down 7.2% from $1.31B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Carnegie Investment Counsel withdrew a net $71M in Q3 2018, closing 70 positions and reducing 101 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $36.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 19% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Carnegie Investment Counsel opened a new position in National Beverage worth $5.44M.
- Carnegie Investment Counsel's largest Q3 2018 buy was National Beverage: 119,794 shares worth $5.44M.
- Carnegie Investment Counsel added most to Northrop Grumman in Q3 2018, an estimated $16.3M increase.
- Carnegie Investment Counsel's biggest Q3 2018 reduction was Visa, cutting an estimated $13.6M.
- Carnegie Investment Counsel fully exited Berkshire Hathaway Class B in Q3 2018, selling an estimated $36.6M.
- Carnegie Investment Counsel's ten largest holdings make up 21% of its $1.22B portfolio in Q3 2018.
- Carnegie Investment Counsel opened 32 new positions and closed 70 in Q3 2018.
- Carnegie Investment Counsel's portfolio value fell 7.2% quarter-over-quarter to $1.22B.
Based on Carnegie Investment Counsel's 13F filing for Q3 2018, filed 27 Nov 2018.